Calcifediol Supplements Market Size, Share, Opportunities, And Trends By Type (Immediate-release calcifediol, Extended-release calcifediol), By Application (Vitamin D Deficiency, Osteoporosis, Secondary hyperparathyroidism, Others), And By Geography - Forecasts From 2025 To 2030

The Calcifediol Supplements Market is expected to grow at a CAGR of 9.21%, reaching a market size of US$2,189.3 million in 2030 from US$1,409.4 million in 2025.

Calcifediol is an active form of Vitamin D found in the bloodstream, also known as 25-hydroxyvitamin D3. It is produced by the liver by hydroxylation of Vitamin D3 that we get from sunlight or diet. It is used to measure the Vitamin D level in the body.  

Calcifediol supplements are a more advanced and powerful type of vitamin D supplement. It has been clinically demonstrated to increase vitamin D levels three times quicker and more efficiently than other methods. Calcifediol monohydrate (25-Hydroxyvitamin D3) is a vitamin D3 analogue created by hydroxylation of vitamin D3 (cholecalciferol) using the enzyme cholecalciferol 25-hydroxylase.

The increasing Vitamin D deficiency worldwide and the aging population are driving the market growth for its supplements. Calcifediol is a better alternative than other forms of Vitamin D supplements as it is absorbed more quickly and increases Vitamin D levels by 3 times in the body, thus leading to an increase in its demand. Moreover, its usage in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis would help in increasing the calcifediol supplements market growth.

What are the calcifediol supplement market drivers?

• Rising Vitamin D deficiency would drive the market growth for calcifediol supplements

Globally, there is an increase in the number of people with Vitamin D deficiency. At the same time, the number of geriatric populations is on the rise worldwide. These factors are creating demand for Vitamin D supplements. Calcifediol is a superior alternative to other vitamin D supplements. It offers an effective solution for addressing vitamin D deficiency, providing a faster and more efficient method to raise vitamin D levels than traditional vitamin D3 supplements.

As per a study done by the National Center of Biotechnology Information, there are 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approximately 30-45% of people have vitamin D deficiency, making it around 1 billion people.

• Increasing health awareness is boosting the calcifediol supplements market

The health and fitness sector is experiencing significant market growth as a greater number of people are becoming aware of their health, especially post-pandemic. The demand for dietary supplements is increasing as people prioritize their health and wellness by supplementing their bodies with micronutrients. Calcifediol Vitamin D Supplement effectively fights vitamin D deficiency and other related problems by increasing vitamin D levels in the blood, thus helping to boost immunity and bone health.

According to a study done by the American Medical Association, between 1994 and 2017, there is an increase in dietary supplements by 86,000 from 4000 to 90,000 products. More than half of the US adults consume dietary supplements, indicating an increased health awareness among the population.  The increased awareness among people for vitamin D supplements would act as a market driving force for the Calcifediol Supplement market.

Segment analysis of the calcifediol supplement market:

• The Calcifediol Supplements market would be dominated by curing Vitamin D Deficiency by application

On the basis of applications where Calcifediol Supplement is used to treat, it is segmented into Vitamin D deficiency, Osteoporosis, Secondary hyperparathyroidism, and others.

During the forecast period, this supplement would be dominated by using it in treating Vitamin D deficiency. Calcifediol is primarily made for supplementing the body with Vitamin D by releasing faster and more efficient vitamin D in the body.

• North America would be the largest market shareholder for calcifediol supplements in the forecast period

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. North America would hold the largest market share for Calcifediol supplements in the forecast period.

North America is experiencing a demographic shift towards the older population. In the United States of America, there are around 77 million people aged above 65, according to the U.S. Census Bureau Project. In Canada, the aging population is increasing, too. Vitamin D deficiency in the aging population, coupled with deficiency in a great number of adults, would significantly increase the demand for calcifediol supplements in the North American region. Though all the regions are facing the issue of vitamin D deficiency, North America, particularly the United States of America, would have the highest growth in the calcifediol supplement market as there are increasing trends among people for dietary supplements and the prevalence of advanced healthcare infrastructure coupled with significant innovations and the advancement in the health sector.

Major restraints in the calcifediol supplement market:

• Limited awareness of Calcifediol Supplements as an alternative for vitamin D deficiency among consumers is hindering its market growth

Though the calcifediol supplement is a better and more advanced alternative for Vitamin D deficiency, the awareness of Calcifediol as a vitamin D supplement is limited when compared to other vitamin D supplements. This limited awareness is a limiting factor in the Calcifediol supplement market growth. Creating more awareness about the product and its advantages over traditional vitamin D supplements can effectively mitigate the restraint and can lead to significant market growth for Calcifediol Supplements.

Key developments in the calcifediol supplement market:

• In May 2024, European union approved DSM-Firmenich’s ampli-D calcifediol supplement as a novel food. This would unlock new opportunities for market expansion in the European Union for DSM-Firmenich, a global innovator in nutrition, health, and beauty.
• In August 2022, Singapore-based firm MD Pharmaceuticals collaborated with DSM to develop a faster-acting vitamin D supplement, branding it as Rapid-D with Calcifediol.
• In January 2021, Australia’s Bioclinic and DSM partnered to launch ampli-D, a Vitamin D Supplement developed and manufactured by DSM. Bioclinic Naturals is the first supplement brand to launch a finished product containing ampli-D.

The calcifediol supplement market is segmented and analyzed as given below:

• By Type
  • Immediate-release calcifediol
  • Extended-release calcifediol
• By Application
  • Vitamin D Deficiency
  • Osteoporosis
  • Secondary hyperparathyroidism
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. CALCIFEDIOL SUPPLEMENTS MARKET BY TYPE 

5.1. Introduction

5.2. Immediate-release calcifediol

5.3. Extended-release calcifediol 

6. CALCIFEDIOL SUPPLEMENTS MARKET BY APPLICATION

6.1. Introduction

6.2. Vitamin D Deficiency

6.3. Osteoporosis

6.4. Secondary hyperparathyroidism

6.5. Others

7. CALCIFEDIOL SUPPLEMENTS MARKET BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. UK

7.4.2. Germany

7.4.3. France

7.4.4. Italy

7.4.5. Others

7.5. Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. Israel

7.5.3. Others 

7.6. Asia Pacific

7.6.1. Japan

7.6.2. China

7.6.3. India

7.6.4. South Korea

7.6.5. Indonesia

7.6.6. Thailand

7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Chemvon Biotechnolgy Co.

9.2. Haoyuan Chemexpress Co. Ltd. 

9.3. BOC Science

9.4. Pharmaffiliates

9.5. DSM-Firmenich 

9.6. Carbogen AMCIS

9.7. Chemicea 

9.8. Midas Pharma

9.9. ApexBio Technolgy

9.10. OPKO Pharmaceuticals LLC

9.11. Nouveau Healthcare

9.12. Tocris Bioscience

Chemvon Biotechnolgy Co.

Haoyuan Chemexpress Co. Ltd. 

BOC Science

Pharmaffiliates

DSM-Firmenich 

Carbogen AMCIS

Chemicea 

Midas Pharma

ApexBio Technolgy

OPKO Pharmaceuticals LLC

Nouveau Healthcare

Tocris Bioscience